Who owns First Tracks Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TRAX from SEC Form 13F filings across 182 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 182 institutions disclosed 36.2M shares of First Tracks Biotherapeutics, Inc. worth $1.28B — about 101.3% of shares outstanding; the largest disclosed holder is EcoR1 Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
182
13F holders
$1.28B
value, 2026 filers
101.3%
of shares outstanding (36.2M sh)
53
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TRAX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EcoR1 Capital, LLC | 3.2M | $112.5M | 5.0% | 8.9% | 0.0% |
| 2 | TCG Crossover Management, LLC | 2.9M | $102.6M | 2.9% | 8.1% | 0.0% |
| 3 | BlackRock, Inc. | 2.6M | $92.0M | 0.0% | 7.3% | +32.3% |
| 4 | Affinity Asset Advisors, LLC | 2.1M | $73.7M | 3.0% | 5.8% | +2.4% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.1M | $73.6M | 0.1% | 5.8% | +184.9% |
| 6 | FMR LLC | 1.7M | $61.9M | 0.0% | 4.9% | -14.9% |
| 7 | STATE STREET CORP | 1.6M | $57.1M | 0.0% | 4.5% | +6.5% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $52.8M | 0.0% | 4.2% | +2.7% |
| 9 | Janus Henderson Group Ltd.NEW | 1.1M | $38.8M | 0.0% | 3.1% | new |
| 10 | BANK OF AMERICA CORP /DE/ | 1.0M | $35.8M | 0.0% | 2.8% | +55.9% |
| 11 | Woodline Partners LP | 917,727 | $32.5M | 0.1% | 2.6% | +0.1% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 836,731 | $29.7M | 0.0% | 2.3% | +19.2% |
| 13 | Sanofi | 821,917 | $29.1M | 4.6% | 2.3% | 0.0% |
| 14 | Trails Edge Capital Partners, LP | 814,000 | $28.8M | 4.1% | 2.3% | -46.2% |
| 15 | Invesco Ltd. | 780,972 | $27.7M | 0.0% | 2.2% | +999.7% |
| 16 | MORGAN STANLEY | 756,492 | $26.8M | 0.0% | 2.1% | -3.2% |
| 17 | Palo Alto Investors LP | 741,097 | $26.3M | 3.9% | 2.1% | +22.8% |
| 18 | STEMPOINT CAPITAL LP | 649,924 | $23.0M | 4.1% | 1.8% | +4.4% |
| 19 | CITADEL ADVISORS LLC | 624,142 | $22.1M | 0.0% | 1.7% | +269.8% |
| 20 | 683 Capital Management, LLC | 600,000 | $21.3M | 0.9% | 1.7% | -20.0% |
| 21 | GOLDMAN SACHS GROUP INC | 502,791 | $17.8M | 0.0% | 1.4% | +3.2% |
| 22 | JENNISON ASSOCIATES LLCNEW | 499,410 | $17.7M | 0.0% | 1.4% | new |
| 23 | BAKER BROS. ADVISORS LPNEW | 472,932 | $16.8M | 0.1% | 1.3% | new |
| 24 | Point72 Asset Management, L.P. | 417,991 | $14.8M | 0.0% | 1.2% | +2.4% |
| 25 | Sofinnova Investments, Inc. | 383,588 | $13.6M | 0.6% | 1.1% | -32.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.